BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16118081)

  • 1. Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series.
    Müller CR; Smeland S; Bauer HC; Saeter G; Strander H
    Acta Oncol; 2005; 44(5):475-80. PubMed ID: 16118081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
    Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
    Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.
    Briccoli A; Rocca M; Salone M; Guzzardella GA; Balladelli A; Bacci G
    Surg Oncol; 2010 Dec; 19(4):193-9. PubMed ID: 19515554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
    Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study.
    Strander H; Bauer HC; Brosjö O; Fernberg JO; Kreicbergs A; Nilsonne U; Silfverswärd C; Signomklao T; Söderlund V
    Acta Oncol; 1995; 34(6):877-80. PubMed ID: 7576758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
    Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
    J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
    Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
    Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.
    Arpaci F; Ataergin S; Ozet A; Erler K; Basbozkurt M; Ozcan A; Komurcu S; Ozturk B; Celasun B; Kilic S; Kuzhan O
    Cancer; 2005 Sep; 104(5):1058-65. PubMed ID: 15999369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
    Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
    Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya in a child treated with interferon for recurrent osteosarcoma.
    Buchbinder D; Steinberg G; Linetsky M; Casillas J
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):476-8. PubMed ID: 20562650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma.
    Bernthal NM; Federman N; Eilber FR; Nelson SD; Eckardt JJ; Eilber FC; Tap WD
    Cancer; 2012 Dec; 118(23):5888-93. PubMed ID: 22648705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.